Improving cancer targeting accuracy in prostate radiotherapy with SeedTracker real-time image guidance system- A Phase I study
Not Applicable
Completed
- Conditions
- Prostate CancerCancer - Prostate
- Registration Number
- ACTRN12618001421224
- Lead Sponsor
- iverpool Hospital Cancer Therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
1.Prostate cancer patients that receive radiotherapy treatment for prostate with current treatment protocol used within Liverpool and Macarthur cancer therapy centres.
2.Patients implanted with three prostate radio opaque markers
3.Patients receiving definitive radiotherapy to the prostate
Exclusion Criteria
1.Patients with hip prosthesis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does SeedTracker real-time image guidance improve tumor localization accuracy in prostate cancer radiotherapy?
What are the clinical outcomes of SeedTracker-guided radiotherapy compared to fiducial marker-based prostate cancer treatment?
Are there biomarkers associated with enhanced response to real-time imaging systems like SeedTracker in localized prostate cancer?
What adverse events are reported with SeedTracker during prostate radiotherapy and how are they managed?
How does SeedTracker's real-time guidance compare to Calypso or AlignRT in prostate cancer treatment efficacy?